2026-03-04 REL RCSB INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY STRUCTURE_SUMMARY atom_site chem_comp database_2 entity pdbx_entity_nonpoly pdbx_nonpoly_scheme pdbx_unobs_or_zero_occ_atoms _atom_site.auth_atom_id _atom_site.auth_comp_id _atom_site.label_atom_id _atom_site.label_comp_id _chem_comp.formula _chem_comp.formula_weight _chem_comp.id _chem_comp.mon_nstd_flag _chem_comp.name _chem_comp.pdbx_synonyms _chem_comp.type _database_2.pdbx_DOI _database_2.pdbx_database_accession _entity.pdbx_description _pdbx_entity_nonpoly.comp_id _pdbx_entity_nonpoly.name _pdbx_nonpoly_scheme.mon_id _pdbx_nonpoly_scheme.pdb_mon_id _pdbx_unobs_or_zero_occ_atoms.auth_atom_id _pdbx_unobs_or_zero_occ_atoms.auth_comp_id _pdbx_unobs_or_zero_occ_atoms.label_atom_id _pdbx_unobs_or_zero_occ_atoms.label_comp_id DATABASE_REFERENCES citation citation_author STRUCTURE_SUMMARY chem_comp_atom chem_comp_bond citation em_3d_fitting_list em_admin pdbx_entry_details pdbx_initial_refinement_model pdbx_modification_feature _citation.journal_id_ISSN _em_3d_fitting_list.accession_code _em_3d_fitting_list.initial_refinement_model_id _em_3d_fitting_list.source_name _em_3d_fitting_list.type _em_admin.last_update _pdbx_entry_details.has_protein_modification REFINEMENT_DESCRIPTION citation em_3d_fitting_list em_admin pdbx_initial_refinement_model _citation.journal_id_ISSN _em_3d_fitting_list.accession_code _em_3d_fitting_list.initial_refinement_model_id _em_3d_fitting_list.source_name _em_3d_fitting_list.type _em_admin.last_update RCSB RCSB 2021-03-12 2021-03-24 2021-03-24 2026-03-04 National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) F32GM128263 United States National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) DP2GM123496 United States National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disease (NIH/NIDDK) 1R01DK106009 United States SN-407-LRRC8A in MSP1E3D1 lipid nanodiscs (Pose-2) Kern DM Gerber EE Ion channel, Inhibitor, MEMBRANE PROTEIN Gunasekar SK Xie L Kumar A Hong J Chheda PR Kang C Kern DM My-Ta C Maurer J Heebink J Gerber EE Grzesik WJ Elliot-Hudson M Zhang Y Key P Kulkarni CA Beals JW Smith GI Samuel I Smith JK Nau P Imai Y Sheldon RD Taylor EB Lerner DJ Norris AW Klein S Brohawn SG Kerns R Sah R Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes. Nat Commun UK 13 784 784 2022 35145074 doi:10.1038/s41467-022-28435-0 2041-1723 Gunasekar SK Xie L Chheda PR Kang C Kern DM My-Ta C Kumar A Maurer J Gerber EE Grzesik WJ Elliot-Hudson M Zhang Y Kulkarni CA Samuel I Smith JK Nau P Imai Y Sheldon RD Taylor EB Lerner DJ Norris AW Brohawn SG Kerns R Sah R Small molecule SWELL1-LRRC8 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes biorxiv US 2021 doi:10.1101/2021.02.28.432901 2692-8205 EMD-23614 other EM volume
Alternate SN-407 Pose
 7m19 FULLOVERLAP EMDB EMD-23614 other EM volume
Alternate SN-407 Pose
 EMDB EMD-23616 associated EM volume
SN-407-LRRC8A in MSP1E3D1 lipid nanodiscs (Pose-2)
 PDB 7M17 unspecified
Alternate SN-407 Pose
 SN407-LRRC8A in MSP1E3D1 lipid nanodiscs (Pose-2) SN407-LRRC8A in MSP1E3D1 lipid nanodiscs (Pose-2) 0 1 Mus musculus Volume-regulated anion channel subunit LRRC8A Mus musculus 0.09525750799999999 6 Spodoptera frugiperda LEVO MIPVTELRYFADTQPAYRILKPWWDVFTDYISIVMLMIAVFGGTLQVTQDKMICLPCKWVTKDSCNDSFRGWAASSPEPT YPNSTVLPTPDTGPTGIKYDLDRHQYNYVDAVCYENRLHWFAKYFPYLVLLHTLIFLACSNFWFKFPRTSSKLEHFVSIL LKCFDSPWTTRALSETVVEESDPKPAFSKMNGSMDKKSSTVSEDVEATVPMLQRTKSRIEQGIVDRSETGVLDKKEGEQA KALFEKVKKFRTHVEEGDIVYRLYMRQTIIKVIKFALIICYTVYYVHNIKFDVDCTVDIESLTGYRTYRCAHPLATLFKI LASFYISLVIFYGLICMYTLWWMLRRSLKKYSFESIREESSYSDIPDVKNDFAFMLHLIDQYDPLYSKRFAVFLSEVSEN KLRQLNLNNEWTLDKLRQRLTKNAQDKLELHLFMLSGIPDTVFDLVELEVLKLELIPDVTIPPSIAQLTGLKELWLYHTA AKIEAPALAFLRENLRALHIKFTDIKEIPLWIYSLKTLEELHLTGNLSAENNRYIVIDGLRELKRLKVLRLKSNLSKLPQ VVTDVGVHLQKLSINNEGTKLIVLNSLKKMVNLTELELIRCDLERIPHSIFSLHNLQEIDLKDNNLKTIEEIISFQHLHR LTCLKLWYNHIAYIPIQIGNLTNLERLYLNRNKIEKIPTQLFYCRKLRYLDLSHNNLTFLPADIGLLQNLQNLAVTANRI EALPPELFQCRKLRALHLGNNVLQSLPSRVGELTNLTQIELRGNRLECLPVELGECPLLKRSGLVVEEDLFSTLPPEVKE RLWRADKEQASNSLEVLFQ Q80WG5 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 0.000744034 18 PEE 7-{[(2S)-2-butyl-6,7-dichloro-2-cyclopentyl-1-oxo-2,3-dihydro-1H-inden-5-yl]oxy}heptanoic acid 0.00046944099999999997 1 YNJ singleParticle particle 1 7.4 20.0 C8H18N2O4S HEPES 150.0 KCl Potassium Chloride
pH to 7.4 with KOH
 Quantifoil R1.2/1.3 GOLD 300 CARBON HOLEY 12.0 ETHANE 100 295.15 FEI VITROBOT MARK IV
2 microliter drop size, manual wait time of 2 seconds, blot force of 1, 3 second blot time.
FEI TALOS ARCTICA FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 200 GATAN K3 (6k x 4k) 51.59 1 CTFFIND 4.1 PHASE FLIPPING AND AMPLITUDE CORRECTION 3.69 FSC 0.143 CUT-OFF RELION 3.1 78324 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD emd_23616.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 360 360 360 0 0 0 360 360 360 409.31998 409.31998 409.31998 90.0 90.0 90.0 X Y Z -0.039576277 0.121268645 0.000017752463 0.0015966721 1.137 1.137 1.137 0.008 AUTHOR SN-407-LRRC8A in MSP1E3D1 lipid nanodiscs (Pose-2) 6NZW PDB experimental model emd_23616_msk_1.map emd_23616_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 360 360 360 0 0 0 360 360 360 409.31998 409.31998 409.31998 90.0 90.0 90.0 X Y Z -0.0532133 0.13779114 0.000017876382 0.0038636313 1.137 1.137 1.137 AUTHOR half-volume 1 emd_23616_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 360 360 360 0 0 0 360 360 360 409.31998 409.31998 409.31998 90.0 90.0 90.0 X Y Z -0.06491539 0.13464567 0.000017597751 0.004036695 1.137 1.137 1.137 AUTHOR half-volume 2